Reversible lesion in the splenium of the corpus callosum

Syuichi Tetsuka1

  • 1Department of Neurology, International University of Health and Welfare Hospital, Nasushiobara, Japan.

Brain and Behavior
|October 8, 2019
PubMed
Abstract

Insights

Reversible lesions in the splenium of the corpus callosum (SCC) on MRI are not exclusive to encephalitis/encephalopathy. These lesions can occur in various conditions and do not always indicate a mild prognosis.

Area of Science:

  • Neurology
  • Radiology
  • Pathophysiology

Background:

  • Isolated, reversible lesions in the splenium of the corpus callosum (SCC) were considered essential for diagnosing mild encephalitis/encephalopathy.
  • Magnetic resonance imaging (MRI) has increased the identification of SCC lesions, revealing inconsistencies in the diagnosis of encephalitis/encephalopathy.

Purpose of the Study:

  • To review the specific clinical and radiological features of encephalitis/encephalopathy.
  • To clarify the diagnostic significance of reversible SCC lesions.

Main Methods:

  • Review of existing literature and case reports on encephalitis/encephalopathy and SCC lesions.
  • Analysis of neuroradiological findings, including diffusion-weighted imaging and apparent diffusion coefficient (ADC) values.

Main Results:

  • Reversible SCC lesions are observed in various diseases, not exclusively in viral encephalitis/encephalopathy, and are considered secondary changes.
  • The presence of SCC lesions does not guarantee a mild condition; symptoms and prognosis can range from absent to severe.
  • Cytokine-mediated cytotoxic edema of the SCC, indicated by specific MRI signals, may be a key pathophysiological mechanism.

Conclusions:

  • Reversible lesions in the SCC on MRI are not pathognomonic for mild encephalitis/encephalopathy.
  • These lesions can be secondary to diverse disorders, and their presence necessitates considering a broader differential diagnosis.
  • The clinical presentation and prognosis associated with SCC lesions vary widely.